RxDoctor Payments Data

Kimberly Duckett, PA

Medical · Millersville, MDNPI 1770037210

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.5% of the total across 334 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,175in general payments, 2019–2025

Across 334 payments — averaging $21.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AbbVie$1K
  • LEO Pharma Inc.$606
  • Sanofi$536
  • Novartis$482
  • Regeneron Healthcare Solutions, Inc.$473
  • plus $3K from 22 others

What the payments were for

  • Food & beverage$6,63793%
  • Education$5377%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,175 in reported general payments places this provider in the 90th percentile of 543 medical providers in Maryland.

See all medical providers in Maryland

Medicare billing

Part B allowed, 2024
$133,932
Medicare patients
507
Services billed
2,341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab24$88,629
Clobetasol Propionate85$6,239
Ketoconazole77$1,820
Metronidazole26$1,733
Betamethasone Valerate43$1,293
Fluorouracil29$1,259
Doxycycline Monohydrate48$1,124
Fluocinolone Acetonide21$884
Triamcinolone Acetonide51$625
Hydroxyzine Hcl22$310
Cephalexin26$277
ValacyclovirValacyclovir Hcl13$271
Hydrocortisone39$147
Fluconazole13$147
Ammonium Lactate13$134

Paid to pharmacies, not to this prescriber.

Other medical in Millersville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →